Trials / Completed
CompletedNCT05317507
Safety of Co-Administered CHI-554 and Alcohol
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Auburn University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, randomized, double-blind study to assess the safety, tolerability, and effects of CHI-554 when co-administered with alcohol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CBD oil | 50 mg |
| DRUG | CBD oil | 100 mg CBD |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2022-05-09
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2022-04-07
- Last updated
- 2025-09-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05317507. Inclusion in this directory is not an endorsement.